Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

763.04
+1.190.16%
Pre-market: 763.040.00000.00%08:32 EDT
Volume:460.42K
Turnover:351.37M
Market Cap:80.67B
PE:18.34
High:768.80
Open:766.83
Low:758.49
Close:761.85
52wk High:821.11
52wk Low:476.49
Shares:105.72M
Float Shares:103.30M
Volume Ratio:0.68
T/O Rate:0.45%
Dividend:3.59
Dividend Rate:0.47%
EPS(TTM):41.59
EPS(LYR):41.48
ROE:14.87%
ROA:5.91%
PB:2.58
PE(LYR):18.40

Loading ...

Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]